News Sarepta slumps on Elevidys patient death The death of a patient treated with Sarepta's Duchenne muscular dystrophy gene therapy Elevidys has hit its share price.
News Eisai to buy "dementia ecosystem" partner EcoNaviSta Eisai's bid to develop an integrated care platform for dementia in Japan has moved forward with the acquisition of remote monitoring firm EcoNaviSta.
News Concern as measles cases doubled in Europe last year A sharp rise in measles cases in 2024 in Europe has led to widespread calls for a concerted effort to ramp up vaccination rates.
News NHS England 'has lost control of health service', says BMA As the news that NHS England is to be dismantled sinks in, the British Medical Association (BMA) and other bodies have weighed in on the decision.
News Trump pulls CDC head nomination as FDA, CDC picks advance President Trump has withdrawn his nomination of Dave Weldon to lead the CDC, hours before he was to appear in front of a Senate confirmation hearing.
News 'Transformational' pill for endometriosis gets NHS nod Around 1,000 women in England a year with endometriosis will soon have access to the first daily oral therapy, Gedeon Richter's Ryeqo, via the NHS.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
